Study Finds Fourfold Increase in Heart Disease Risk for Women with PMOS

A recent American study has identified a significant health risk for women diagnosed with Polycystic Multiple Endocrine Syndrome (PMOS), indicating that their likelihood of developing heart disease is four times greater than that of women without the condition. This finding underscores the importance of addressing this syndrome with increased medical attention.

PMOS is a complex hormonal disorder prevalent among women, impacting various health aspects such as hair growth, menstrual cycle regularity, fertility, and mood fluctuations.

Previously referred to as "Polycystic Ovary Syndrome," the condition's name was updated to correct misconceptions. Earlier focus on ovarian cysts alone delayed diagnosis in many cases, despite the syndrome's broader health effects.

The study, as reported by the British newspaper The Independent, analyzed health insurance data from over 413,000 women aged between 18 and 50 diagnosed with PMOS. Their data were compared with that of more than two million women without the syndrome, covering the period from 2000 to 2022.

Findings revealed that the increased risk of heart disease persisted even after excluding influencing factors such as high blood pressure and diabetes, suggesting a direct link between PMOS and elevated chances of cardiovascular problems.

Researchers emphasized that these results highlight the necessity to raise awareness among both medical professionals and women regarding the cardiac risks associated with PMOS. They advocate for enhanced early detection and preventive measures before complications arise.

The study team, publishing their work in The Lancet journal, stated that improving medical education and increasing patients' understanding of the risks could contribute to developing better prevention strategies and reducing the incidence of heart disease among affected women.